Memory, Learning and Cognition
Cognition is the term used to define the process of thoughts, including memory, awareness, reasoning and perception. Cognitive enhancement describes the improvement of the information processing systems of the mind and the extension of its main capacities, which can be undertaken simply by learning, especially during early development.
Memory, Learning and Cognition Products Targets
- Voltage-gated Calcium Channel (CaV) (38)
- Others (13)
- D4 Receptor (12)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- Protein Kinase C (29)
- Calmodulin-Dependent Kinase (8)
- D3 Receptor (12)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Amyloid beta Peptide (28)
- Histamine H1 Receptor (17)
- M5 Receptor (2)
- M4 Receptor (3)
- M3 Receptor (4)
- M2 Receptor (5)
- M1 Receptor (8)
- Delta opioid receptor (16)
- Protein serine and threonine phosphatase (16)
- Histone Deacetylase (19)
- Phosphodiesterase (34)
Products for Memory, Learning and Cognition - Page 35
- Cat.No. Product Name Information/Activity
-
BCC6790
(+)-UH 232 maleate
1217473-50-1
-
BCC2072
Ziprasidone hydrochloride monohydrate
Ziprasidone hydrochloride monohydrate (CP 88059 hydrochloride monohydrate) is a combined 5-HT (serotonin) and dopamine receptor antagonist which exhibits potent effects of antipsychotic activity.
-
BCC6353
PAOPA
114200-31-6
-
BCC6756
7-Hydroxy-DPAT hydrobromide
76135-30-3
-
BCC6760
7-Hydroxy-PIPAT maleate
200722-46-9
-
BCN2181
Pramipexole dihydrochloride
Pramipexole dihydrochloride is a partial/full D2S, D2L, D3, D4 receptor agonist with a Ki of 3.9, 2.2, 0.5 and 5.1 nM for D2S, D2L, D3, D4 receptor, respectively.
-
BCC7193
Eticlopride hydrochloride
97612-24-3
-
BCC7025
Nafadotride
149649-22-9
-
BCC7435
NGB 2904
189061-11-8
-
BCC7801
PG 01037 dihydrochloride
675599-62-9
